Pelagos Insurance Capital Ltd (PLGO): Financial results for Q2 2026

Pelagos Insurance Capital Ltd (PLGO) furnished an SEC Form 6-K — earnings release. Pelagos Insurance Capital Reports Second Quarter 2026 Results Gross premiums written of $1.3 billion, growth of 6.4% from the second quarter of 2025 Growth of 23% in book value per diluted common share including cumulative dividends from June 30, 2025 Second Quarter 2026 Highligh

Original reporting
Published Aug 12, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PLGO
Bullish
high confidence
Mentioned
$PLGO
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$PLGOBullishMed
01

Why it matters

The earnings release provides fresh profitability metrics and capital return figures, offering traders actionable data.

02

Market read

First‑report earnings for a niche insurer; may influence sector peers and insurance‑focused funds.

03

What to watch

Catastrophe losses rose to $161.8M YoY, which may pressure future profitability.

Relevance 7/10Novelty 8/10Timing: after-hours earnings release on Aug 12, 2026

Background

Pelagos Insurance Capital Ltd (NYSE: PLGO) filed a Form 6‑K with the SEC presenting its Q2 2026 financial results.

Company-level read

Ticker impact

$PLGOBullishHigh confidence
Context

Q2 2026 earnings report shows net income $44.4M, combined ratio 99.5% and $72.6M returned to shareholders.

Expected impact

Modest upside as investors price improved underwriting results and higher ROAE.

Evidence & confidence

Improved combined ratio and strong capital return signal operational strength, which can attract buying.

Market effects

Better underwriting results may lift sentiment in the specialty insurance sector.

Positive for Bermuda‑based insurers and U.S. listed insurance stocks.

Limited to insurance investors; no broad market effect.

Counterpoint

Higher premiums could mask underlying exposure to catastrophe losses; watch for future loss development.

Key entities

  • Pelagos Insurance Capital Ltd

    Specialty insurance and reinsurance firm listed on NYSE.

  • Dan Burrows

    Group Chief Executive Officer of Pelagos.

Related articles

$PLGOMed

Fidelis Insurance Q2 Earnings Call Highlights

Fidelis Insurance (FIHL) reported Q2 earnings call highlights. Management said Middle East war-related business since the conflict began had a loss ratio below 20%, and the broader war book generated over $1B premium at a sub-20% loss ratio. Quarterly combined ratio was 93.1%, with net favorable prior-year reserve development of $33M. Pelagos returned $73M via buybacks and maintained its dividend, reaffirming a mid-40% overall loss ratio.

$DNAMed

Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors

Ginkgo Bioworks (NYSE:DNA) reported a strategic shift toward commercializing autonomous lab hardware and cloud services during its Q3 2026 earnings call. Key points include selling hardware to biopharma partners, restructuring to reduce cash burn, and AI-driven demand for lab data. The company ended the quarter with $285M in cash and no debt. Novo Nordisk is a notable partner.